GI Windows Competitors and Similar CompaniesClear all
GI Windows's competitors and similar companies include Impact Cryotherapy, Tandem Diabetes Care, Cell MedX and Ypsomed.
 GI Windows GI Windows is a clinical-stage medical device company specializing in non-surgical treatment of type-2 diabetes and obesity. |  Impact Cryotherapy Impact Cryotherapy is a company that specializes in Cryosauna manufacturing and chill therapies. |  Tandem Diabetes Care Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. |  Cell MedX Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. |  Ypsomed Ypsomed is a company that develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. | |
Founding Date | Founding Date 2012 | Founding Date N/A | Founding Date 2006 | Founding Date 2014 | Founding Date 2003 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Westwood, US HQ | Locations HQ | Locations San Diego, US HQ Markham, CA Schiphol, NL | Locations Carson City, US HQ | |
Employees | Employees 244% increase | Employees 6 | Employees 2,65010% increase | Employees 150% decrease | Employees 2,60013% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.2 b | Valuation ($) 8.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) CHF748.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $468.7m (FY, 2025) | Cost of goods N/A | Cost of goods CHF351.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $546m (FY, 2025) | Gross profit N/A | Gross profit CHF398.8m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($204.7m) (FY, 2025) | Net income ($566.3k) (FY, 2025) | Net income CHF87.5m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 42.9m | Total funding raised N/A | Total funding raised $ 401.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Impact Cryotherapy
HQ
Employees
6
Impact Cryotherapy is a company that specializes in Cryosauna manufacturing and chill therapies.
View companyTandem Diabetes Care
HQ
San Diego, US
Employees
2,650↑ 10% increase
Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes.
View companyCell MedX
HQ
Carson City, US
Employees
1↓ 50% decrease
Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.
View companyYpsomed
HQ
Burgdorf, CH
Employees
2,600↑ 13% increase
Ypsomed is a company that develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies.
View company